Emerald Advisers’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,107
| Closed | -$261K | – | 250 |
|
|
2023
Q4 | $261K | Sell |
2,107
-28
| -1% | -$3.48K | 0.01% | 208 |
|
|
2023
Q3 | $199K | Sell |
2,135
-46
| -2% | -$4.29K | 0.01% | 206 |
|
|
2023
Q2 | $280K | Sell |
2,181
-31
| -1% | -$3.98K | 0.01% | 198 |
|
|
2023
Q1 | $257K | Sell |
2,212
-2,452
| -53% | -$285K | 0.01% | 201 |
|
|
2022
Q4 | $528K | Sell |
4,664
-79
| -2% | -$8.95K | 0.03% | 164 |
|
|
2022
Q3 | $382K | Sell |
4,743
-37
| -0.8% | -$2.98K | 0.02% | 188 |
|
|
2022
Q2 | $356K | Hold |
4,780
| – | – | 0.02% | 190 |
|
|
2022
Q1 | $611K | Sell |
4,780
-92
| -2% | -$11.8K | 0.02% | 179 |
|
|
2021
Q4 | $654K | Sell |
4,872
-2,876
| -37% | -$386K | 0.02% | 180 |
|
|
2021
Q3 | $1.06M | Buy |
7,748
+1,800
| +30% | +$246K | 0.04% | 151 |
|
|
2021
Q2 | $635K | Buy |
+5,948
| New | +$635K | 0.02% | 181 |
|